Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - CHANGE IN WORKING CAPITAL
Change in Working Capital TRVI - Trevi Therapeutics, Inc.
-3.85 M
LAST VALUE
-88.40%
2 YEAR CAGR
-46.61%
5 YEAR CAGR
0.00%
10 YEAR CAGR